Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Alpha Teknova Sees FY24 Revenue $35M-$38M Vs $41.49M Est.

Author: Benzinga Newsdesk | March 11, 2024 04:41pm

2024 Outlook

Teknova anticipates total revenue of $35 million to $38 million for the fiscal year ending December 31, 2024 ("2024"), which assumes roughly 10% growth in Lab Essentials and the remaining revenue from Clinical Solutions. The Company also anticipates free cash outflow of less than $18 million for 2024.

Posted In: TKNO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist